Gary Luker, MD appointed as Faculty Director of the Microscopy Core
Karl Jepsen, M.D., Ph.D., associate dean for research, recently announced the appointment of
Karl Jepsen, M.D., Ph.D., associate dean for research, recently announced the appointment of
Atonco, a French biotechnology company, and University of Michigan Health today announced a collaborative agreement to conduct a Phase 1-2a clinical study evaluating Atonco's ATO-101™ ([211At] At-anti-CA-IX antibody) targeted alpha therapy candidate in non-muscle invasive bladder cancer (NMIBC).
Research activities within Radiology and other medical departments has led to the development of a new anti-cancer agent published in Nature Communications. The publication describes a new drug candidate that is orally delivered and is absorbed in the gut directly into the lymphatic system. Development and demonstration of a “lymphatropic”
After receiving one of only six prototypes of the Siemens Healthineers Free.Max in the world, the Michigan Medicine Department of Radiology installed the low-field MRI scanner. The device has a reduced field strength of .55 Tesla, which lowers cost and could improve image quality in certain settings. The scanner also provides a step towards low
Discovery holds promise for developing urgently needed new therapies in serious lung disease
The latest in imaging, mechanisms of injury and treatment: A Q&A with Corrie M. Yablon, M.D.
Three UMMS colleagues have been working to build collaborations with faculty in their native Macedonia. From left: visiting Macedonian scholar Daniela Miladinova; Assistant Professor of Internal Medicine Vladimir Ognenovski; Associate Professor of Pathology Zaneta Nikolovska-Coleska; and Assistant Professor of Radiology Jadranka Stojanovska.
Nearly a year in the making, the first annual Frankel Cardiovascular Center (FCVC) Clinical Innovation Challenge celebrated its “Selection Event” on December 8. Over 100 faculty, staff, and guests attended the celebration, which brought the 2016 Clinical Innovation Challenge to a close. Guests heard pitches from the Challenge’s top five teams,
Peter Scott spent his Time4Chem writing about his experiences as an international chemist and the importance of collaboration across borders